For example, in addition to the Ras-MAPK pathway, activated by mutation in e.g. the KRAS gene, other pathways important in carcinoma development are the TGFβ pathway, disrupted by mutation in e.g. SMAD4, and the TP53 pathway, disrupted by mutations in the TP53 gene4,5. Here, TP53 is linked to carcinoma.